Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety and efficacy of the study drug compared to placebo in
the treatment of cognitive impairment in men with schizophrenia.